Search

Your search keyword '"Di Nottia, Michela"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Di Nottia, Michela" Remove constraint Author: "Di Nottia, Michela"
36 results on '"Di Nottia, Michela"'

Search Results

3. Severe mitochondrial encephalomyopathy caused by de novo variants in OPA1 gene.

4. De Novo DNM1L Mutation in a Patient with Encephalopathy, Cardiomyopathy and Fatal Non-Epileptic Paroxysmal Refractory Vomiting.

5. Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia

8. Inflammatory profile in mitochondrial diseases: A cohort study

10. Novel mutations in IBA57 are associated with leukodystrophy and variable clinical phenotypes

11. Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement

12. Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration

13. Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement

14. Hyperactive HRAS dysregulates energetic metabolism in fibroblasts from patients with Costello syndrome via enhanced production of reactive oxidizing species

16. Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism

17. A novel homozygous variant in COX5A causes an attenuated phenotype with failure to thrive, lactic acidosis, hypoglycemia, and short stature.

18. Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation

20. A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly

21. Mutations inELAC2associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3′‐end processing

22. Clinical-genetic features and peculiar muscle histopathology in infantileDNM1L-related mitochondrial epileptic encephalopathy

23. ISCA1 mutation in a patient with infantile-onset leukodystrophy causes defects in mitochondrial [4Fe–4S] proteins

24. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations

25. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations

26. Novel mutation in mitochondrial Elongation Factor EF-Tu associated to dysplastic leukoencephalopathy and defective mitochondrial DNA translation

27. Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3′‐end processing.

28. Clinical‐genetic features and peculiar muscle histopathology in infantile DNM1L‐related mitochondrial epileptic encephalopathy.

29. Novel mutations in IBA57 are associated with leukodystrophy and variable clinical phenotypes

30. Biallelic mutations in early-onset, variably progressive neurodegeneration.

31. Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2

32. Enhancement of mitochondrial ATP production by theEscherichia colicytotoxic necrotizing factor 1

34. Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3'-end processing

35. TERT Extra-Telomeric Roles: Antioxidant Activity and Mitochondrial Protection

36. Hyperactive HRAS dysregulates energetic metabolism in fibroblasts from patients with Costello syndrome via enhanced production of reactive oxidizing species.

Catalog

Books, media, physical & digital resources